September 30 - October 1, 2017    london , United Kingdom
During the EASL-AASLD joint meeting on "Definition, therapeutic advances and clinical endpoints in alcoholic liver disease and alcoholic hepatitis" topics on public health, diagnostic definitions, therapeutic advances and clinical endpoints in alcohol related liver disease and alcoholic hepatitis will be discussed. Alcohol related liver disease (ALD) is the most prevalent cause of advanced liver disease and liver related mortality in Western countries. Research in ALD spans a wide spectrum from public health to basic science and despite being the ‘Cinderella’ disease area in hepatology, there have been a number of advances in recent years. We would like to take this opportunity to review with you the emerging data from clinical, translational and basic science studies in ALD. The organisers: Prof. Philippe Mathurin, Prof. Vijay Shah, Prof. Gyongyi Szabo and Prof. Mark Thursz Website:


Location: Pullman London St Pancras
Contact 100 - 110 Euston Rd, London NW1 2AJ, United Kingdom london , United Kingdom
+44 20 7666 9000


European Association for the study of Liver
7 rue des Battoirs 1205 Geneva Switzerland
+41 (0) 22 807 03 60